Workflow
What Makes Aveanna Healthcare (AVAH) a Strong Momentum Stock: Buy Now?
ZACKS· 2025-08-20 17:01
Group 1: Momentum Investing Overview - Momentum investing involves following a stock's recent trend, with the strategy of buying high and selling higher, capitalizing on established price movements [1] - The Zacks Momentum Style Score helps investors identify stocks with momentum by focusing on key metrics [2] Group 2: Aveanna Healthcare (AVAH) Analysis - Aveanna Healthcare currently holds a Momentum Style Score of A and a Zacks Rank of 1 (Strong Buy), indicating strong potential for outperformance [3][4] - Over the past week, AVAH shares increased by 15.31%, significantly outperforming the Zacks Medical - Outpatient and Home Healthcare industry, which rose by 1.01% [6] - In a longer timeframe, AVAH shares have risen by 33.4% over the past quarter and 42.27% over the past year, while the S&P 500 only increased by 7.87% and 15.7%, respectively [7] Group 3: Trading Volume and Earnings Outlook - The average 20-day trading volume for AVAH is 1,672,211 shares, indicating a bullish sign with rising stock prices [8] - Over the past two months, three earnings estimates for AVAH have increased, raising the consensus estimate from $0.22 to $0.35 [10] - The positive earnings revisions suggest a promising outlook for AVAH, reinforcing its status as a 1 (Strong Buy) stock with a Momentum Score of A [12]
Dell Technologies (DELL) Is Up 0.49% in One Week: What You Should Know
ZACKS· 2025-08-20 17:01
Company Overview - Dell Technologies currently holds a Momentum Style Score of B, indicating a positive outlook based on its recent performance metrics [2] - The company has a Zacks Rank of 2 (Buy), suggesting strong potential for outperformance in the market [3] Price Performance - Over the past week, Dell's shares increased by 0.49%, while the Zacks Computer - Micro Computers industry rose by 0.73% [5] - In a longer time frame, Dell's shares have appreciated by 8.74% over the past month, outperforming the industry's 7.65% [5] - Over the last quarter, Dell's shares have risen by 18.61%, and they are up 22.12% over the past year, significantly outperforming the S&P 500, which increased by 7.87% and 15.7% respectively [6] Trading Volume - Dell's average 20-day trading volume is 4,426,363 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the past two months, two earnings estimates for Dell have been revised upwards, while none have been lowered, leading to an increase in the consensus estimate from $9.43 to $9.47 [9] - For the next fiscal year, one estimate has moved upwards with no downward revisions during the same period [9] Conclusion - Given the positive momentum indicators and earnings outlook, Dell Technologies is positioned as a strong candidate for investment, reflected in its 2 (Buy) rating and Momentum Score of B [11]
Draganfly (DPRO) Upgraded to Buy: What Does It Mean for the Stock?
ZACKS· 2025-08-20 17:01
Core Viewpoint - Draganfly Inc. (DPRO) has received an upgrade to a Zacks Rank 2 (Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Movement - The Zacks rating system reflects changes in earnings estimates, which are strongly correlated with near-term stock price movements [4][6]. - An increase in earnings estimates typically leads to higher fair value calculations by institutional investors, resulting in buying or selling pressure that affects stock prices [4]. Recent Performance and Outlook - Draganfly's earnings estimates have seen a notable increase, with the Zacks Consensus Estimate rising by 37.9% over the past three months [8]. - For the fiscal year ending December 2025, the expected earnings per share for Draganfly is -$1.52, unchanged from the previous year [8]. Zacks Rank System - The Zacks Rank system categorizes stocks into five groups based on earnings estimates, with Zacks Rank 1 (Strong Buy) stocks historically generating an average annual return of +25% since 1988 [7]. - Draganfly's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating strong potential for market-beating returns in the near term [10].
All You Need to Know About Norsk Hydro ASA (NHYDY) Rating Upgrade to Buy
ZACKS· 2025-08-20 17:01
Investors might want to bet on Norsk Hydro ASA (NHYDY) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Individual inves ...
Dell Technologies (DELL) Upgraded to Buy: Here's What You Should Know
ZACKS· 2025-08-20 17:01
Dell Technologies (DELL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.The power o ...
Sagimet Biosciences Inc. (SGMT) Upgraded to Buy: What Does It Mean for the Stock?
ZACKS· 2025-08-20 17:01
Group 1 - Sagimet Biosciences Inc. (SGMT) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive trend in earnings estimates which is a significant factor influencing stock prices [1][4][6] - The Zacks rating system focuses on a company's earnings picture, tracking the Zacks Consensus Estimate for EPS from sell-side analysts, which reflects the company's future earnings potential [2][5] - The recent increase in earnings estimates for Sagimet Biosciences suggests an improvement in its underlying business, likely leading to increased stock price due to investor interest [6][9] Group 2 - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly Zacks Rank 1 stocks averaging a +25% annual return since 1988 [8][10] - Sagimet Biosciences is expected to earn -$1.85 per share for the fiscal year ending December 2025, with a 25.6% increase in the Zacks Consensus Estimate over the past three months [9][11] - The upgrade to Zacks Rank 2 places Sagimet in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10][11]
All You Need to Know About FirstCash (FCFS) Rating Upgrade to Buy
ZACKS· 2025-08-20 17:01
Core Viewpoint - FirstCash Holdings (FCFS) has been upgraded to a Zacks Rank 2 (Buy) due to an upward trend in earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system is based on a company's changing earnings picture, which is crucial for near-term stock price movements [2][4]. - An increase in earnings estimates typically leads to higher fair value calculations by institutional investors, resulting in buying or selling actions that affect stock prices [4]. Company Performance and Outlook - The upgrade for FirstCash indicates a positive outlook for its earnings, suggesting potential buying pressure and an increase in stock price [3][5]. - FirstCash is expected to earn $8.03 per share for the fiscal year ending December 2025, with a 1.3% increase in the Zacks Consensus Estimate over the past three months [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong track record of performance, particularly for Zacks Rank 1 stocks, which have generated an average annual return of +25% since 1988 [7]. - The upgrade of FirstCash to a Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10].
GeoVax Labs (GOVX) Upgraded to Buy: What Does It Mean for the Stock?
ZACKS· 2025-08-20 17:01
GeoVax Labs Inc. (GOVX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.The power of a cha ...
Anika (ANIK) Upgraded to Buy: Here's What You Should Know
ZACKS· 2025-08-20 17:01
Core Viewpoint - Anika Therapeutics has been upgraded to a Zacks Rank 2 (Buy) due to an upward trend in earnings estimates, which is a significant factor influencing stock prices [1][2]. Earnings Estimates and Stock Price Movement - The Zacks rating system is based on the consensus measure of EPS estimates from sell-side analysts, reflecting the company's changing earnings picture [1][2]. - Changes in future earnings potential, as indicated by earnings estimate revisions, are strongly correlated with near-term stock price movements [3][5]. Institutional Investor Influence - Institutional investors utilize earnings estimates to determine the fair value of a company's shares, impacting stock price through their large transactions [3]. Business Improvement Indicators - Rising earnings estimates and the Zacks rating upgrade suggest an improvement in Anika's underlying business, which could lead to higher stock prices as investors respond positively [4][9]. Earnings Estimate Revisions for Anika - Anika is projected to earn -$0.14 per share for the fiscal year ending December 2025, with no year-over-year change [7]. - Over the past three months, the Zacks Consensus Estimate for Anika has increased by 7.8% [7]. Zacks Rank System Overview - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have generated an average annual return of +25% since 1988 [6][8]. - Anika's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for near-term price appreciation [9].
Sony raises PlayStation 5 prices in U.S. as tariffs start to hit
CNBC· 2025-08-20 17:00
Price Increase Announcement - Sony announced a price increase for PlayStation 5 consoles in the U.S., with the Digital Edition rising from $450 to $500, the disc version from $500 to $550, and the PlayStation 5 Pro from $700 to $750 [1] Tariff Impact - The U.S. has a 30% tariff on imports from China, and Japan, Sony's home country, faces a 15% tariff. While Sony did not directly link the price increase to these tariffs, consumer companies have been warning of higher prices due to tariffs [2] Economic Environment - Sony acknowledged the challenging economic environment and stated that retail prices for console accessories, such as controllers, have not changed. The company is working on supply chain diversification to mitigate the impact of U.S. tariffs, with console hardware sold in the U.S. produced outside of China [3] Pricing Strategy - Sony officials indicated that their hardware pricing strategy is linked to future competitive strategies and will be flexible based on consumer price sensitivity, total segment profits, lifetime value, and sales potential. Other companies in the industry, like Microsoft and Nintendo, have also adjusted their pricing strategies in response to tariffs [4]